|Bid||102.42 x 900|
|Ask||103.80 x 900|
|Day's Range||102.92 - 104.78|
|52 Week Range||72.13 - 122.15|
|Beta (5Y Monthly)||0.69|
|PE Ratio (TTM)||31.59|
|Forward Dividend & Yield||2.32 (2.22%)|
|Ex-Dividend Date||Sep. 24, 2020|
|1y Target Est||N/A|
BRAMPTON, ON, Sept. 15, 2020 /CNW/ - Medtronic Canada ULC, a subsidiary of Medtronic plc (NYSE: MDT) — one of the world's largest medical technology, services, and solutions companies — announced today that it has been recognized as one of the Best Workplaces in Healthcare for the second consecutive year.
DUBLIN, Sept. 11, 2020 /CNW/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate virtually in the Morgan Stanley 18th Annual Global Healthcare Conference on Monday, September 14, 2020.
* PRODIGY Study Provides First Validated Risk Prediction Tool to Guide Continuous Monitoring for Opioid-Induced Respiratory Depression (OIRD) * OIRD Occurred in 46% of Patients Studied * Patients with Respiratory Depression Are 37% More Likely to Experience an Adverse Event and Require Longer Hospital StaysDUBLIN, Sept. Importantly, conclusions from the study data enabled the development of the PRODIGY Risk Score, an easy-to-use risk prediction tool to identify patients at high risk of respiratory depression who would benefit from continuous monitoring with capnography and pulse oximetry.